Stock listing
Inhibikase Therapeutics, Inc.
Selected listing: IQT0 · MUN · EUR · DE
Inhibikase Therapeutics, Inc. (Munich:IQT0), Health Technology. Latest release Oct 2, 2026: Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq…
- Ticker
- Munich:IQT0
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Munich
- Currency
- EUR
Latest news from Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity
August 11, 2026
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
July 23, 2026
Inhibikase Therapeutics Announces Sale of $50 Million of Shares through its At-the-Market Facility
July 15, 2026
Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility
July 14, 2026
Events
Research Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. company profile
View the public company page for Inhibikase Therapeutics, Inc. on 6ix.
Inhibikase Therapeutics, Inc. news
Read company news and market updates connected to Inhibikase Therapeutics, Inc..
Inhibikase Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Inhibikase Therapeutics, Inc..
Alternate listings
IKT:NASDAQ
US · USD
Alternate listing for Inhibikase Therapeutics, Inc.; the primary context on this page is IQT0:MUN.
IQT0:GETTEX
DE · EUR
Alternate listing for Inhibikase Therapeutics, Inc.; the primary context on this page is IQT0:MUN.
IKT:BOATS
US · USD
Alternate listing for Inhibikase Therapeutics, Inc.; the primary context on this page is IQT0:MUN.
IQT0:SWB
DE · EUR
Alternate listing for Inhibikase Therapeutics, Inc.; the primary context on this page is IQT0:MUN.